Skip to content
Cancer — Tyrosine kinase inhibitorsATC L01EB02

Erlotinib

Prescription onlyWHO essential medicine

EGFR tablet for lung cancers with EGFR mutations.

Starts working
Depends on the cancer and regimen
Half-life
About 36 hours
In use since
—
Pregnancy
Usually avoided

Overview

Erlotinib blocks the EGFR enzyme in tumours with activating mutations. It commonly causes acne-like rash and diarrhoea. Newer drugs such as osimertinib are often used first.

Conditions it's used for

How it works

Blocks a growth signal in EGFR-mutated lung cancer.

Erlotinib belongs to the Tyrosine kinase inhibitors. How Tyrosine kinase inhibitors work: block a faulty 'on switch' protein that a cancer depends on.

Uses

  • EGFR-mutated non-small-cell lung cancer
  • Pancreatic cancer (with gemcitabine)

Available as: tablet.

Typical dose

Adults
Dosed by your cancer team according to the treatment protocol.
Good to know
Doses depend on body size, blood counts and the regimen.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Acne-like rash
  • Diarrhoea
  • Dry skin
  • Loss of appetite
  • Tiredness

Serious — get medical help

Uncommon, but need prompt attention

  • Lung inflammation
  • Liver failure
  • Bowel perforation
  • Eye problems

Warnings

  • Take on an empty stomach
  • Stop smoking: it lowers levels

Who should avoid it

  • Pregnancy
  • Severe liver impairment

Interactions

  • Warfarin — INR rises
  • PPIs and H2 blockers — reduced absorption
  • Ketoconazole, ciprofloxacin — raised levels
  • Rifampicin — lower levels

Other medicines in the atlas that need care with Erlotinib, grouped by the reason:

Reduced effectModerateWith Carbamazepine, Efavirenz, Enzalutamide, Griseofulvin, Modafinil and 5 more

Enzyme induction lowers levels of this medicine, which may stop it working.

What's usually done: Monitor effect; dose changes or alternatives may be needed. The effect lasts weeks after stopping the inducer.

Raised drug levelsModerateWith Clarithromycin, Darunavir, Erythromycin, Itraconazole, Lopinavir-ritonavir and 2 more

Blocking CYP3A4 increases levels of this medicine, so side effects become more likely.

What's usually done: A dose reduction, alternative or extra monitoring may be needed.

Check Erlotinib against your own medicines

Using it safely

Alcohol
Best to limit. Alcohol may add to liver strain.
Food and drink
Take on an empty stomach, at least 1 hour before or 2 hours after food.
If you miss a dose
Skip and take the next dose as normal.
Stopping it
Only on advice of your cancer team.
Driving
Tiredness may affect driving.
Tests and checks
Liver tests; Rash; Breathing
If too much is taken
Seek medical advice.
Storage
Room temperature.
Legal status
United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)

Pregnancy and breastfeeding

Pregnancy

Usually avoided

Avoid.

Breastfeeding

Usually avoided

Avoid.

Special groups

Kidney disease
Dose may need adjusting; your team will advise.
Liver disease
Dose may need adjusting; your team will advise.
Older adults
Older adults may be more sensitive to side effects.

Brand names

United States
Tarceva
United Kingdom
Tarceva
India
Tarceva, Erlonib, Erlotinib (generic)
Australia
Tarceva

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Do I need a prescription for Erlotinib?

Yes — Erlotinib is prescription-only in most countries.

Can I take Erlotinib during pregnancy?

Usually avoided. Avoid. Always check with a doctor or midwife.

How quickly does Erlotinib work?

Depends on the cancer and regimen.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.